MENU
Anatomy
Anesthesiology
Biochemistry
Biomedical Informatics
Biophysics
Cell Biology
Clinical Cases
Dentistry
Dermatovenerology
Emergency Medicine
Family Medicine
Forensic Medicine
Gynecology and Obstetrics
Histology and Embryology
History of Medicine
Human Genetics
Hygiene
Infectious Diseases
Internal Medicine
Medical Deontology and Philosophy
Medical Psychology
Microbiology and Immunology
Neurology
Occupational Medicine
Oncology
Ophthalmology
Orthopaedics
Otorhinolaryngology
Pathology
Pathophysiology
Pediatrics
Pharmacology and Experimental Toxicology
Physical and Rehabilitation Medicine
Physiology
Psychiatry
Radiology
Social Medicine
Surgery
Toxicology
Research papers
Clinical research paper
Preclinical research paper
Sponsored articles
Archive » 2013 » 2 » | Archive » Medical field » Fields » Biochemistry » Archive » Medical field » Fields » Neurology » Archive » Medical field » Fields » Pharmacology and Experimental Toxicology »

Histamine Receptor Type 3 – from Gene to Drug Target

 
Abstract:

This post is also available in: enEnglish slSlovenščina (Slovenian)

Histamine receptor type 3 was discovered in 1983 by Schwartz and coworkers and cloned in 1999. The expression of histamine receptor type 3 is largely confined to the central nervous system, where differential transcriptional and posttranscriptional processing lead to a high degree of molecular and functional heterogeneity. Histamine receptor type 3 has unique properties including constitutive activity in vivo and the recruitment of plasticity-related signal transduction pathways, including Gαi/o-proteins, adenylyl cyclase, phospholipase A2, mitogen-activated protein kinase and Akt/glycogen synthase kinase 3 signalling. These make the histamine receptor type 3 the most prominent target for histaminergic drug development. Histamine receptor type 3 can function both as an autoreceptor and as a heteroreceptor. As an autoreceptor on histaminergic neurons, histamine receptor type 3 activation inhibits cell firing, histamine synthesis and release. As a presynaptic heteroreceptors on other neurons, histamine receptors type 3 abundantly control the outflow of various neurotransmitters, including biogenic amines, acetylcholine, glutamate and γ-amino butyric acid. The histamine receptor type 3 functioning is associated with cognition, behaviour, wakefulness and sleep regulation, locomotion, appetite regulation and pain perception.

Authors:
Žiberna Lovro, Jurič Damijana Mojca

Keywords:
histamine, histamine receptor type 3, intracellular signalling, ligands, central nervous system, neuropharmacology

Cite as:
Med Razgl. 2013; 52: 255–70
© 2022 Društvo Medicinski razgledi | Na vrh strani / To top ↑